EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Column-Shipped 211At for Targeted Alpha Therapy: High Radiochemical Conversion in Organotin Astatination via Redox Activation

Jehan S. Perera, Jennifer M. Pyles, Christine C. Lawrence, Gabriel C. Tabacaru, Shayden R. Fritz, Lauren A. McIntosh, Sherry J. Yennello, Jonathan D. Burns

ACS Organic & Inorganic Au · 02.11.2026

DOI: 10.1021/acsorginorgau.6c00088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Organic & Inorganic Au, online erschienen am 02.11.2026. Verfasst von Jehan S. Perera und 7 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nuclear Physics, Office of Isotope Research and Development and Production, National Nuclear Security Administration.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astatine-211 is a rare heavy halogen radionuclide whose ability to form covalent carbon–astatine bonds confers distinctive chemical behavior, yet its broader application remains limited by tracer-level availability and complex aqueous speciation. Because production is restricted to a small number of specialized cyclotron facilities worldwide, direct on-site access is impractical for most research and clinical centers; accordingly, distribution from centralized production sites via column-based conveyance provides a practical strategy for expanding access to this promising α-emitter for targeted alpha therapy. This study demonstrates that oxidative activation of column-recovered 211At generates a reactive astatine species that enables efficient labeling of aryl-organotin precursors under mild, catalyst-free conditions. Structurally diverse substrates, including chloro-substituted arylstannanes, guanidyl-functionalized benzyl derivatives, and heteroaryl thiophenes, undergo rapid astatination with radiochemical conversions of 83–95%. This work establishes a practical and electronically tunable platform for 211At radiochemistry using column-shipped material, helping extend astatination chemistry beyond specialized cyclotron facilities.

Förderung

  • Nuclear Physics
  • Office of Isotope Research and Development and Production
  • National Nuclear Security Administration

Zitieren

APA

Perera, J. S., Pyles, J. M., Lawrence, C. C., Tabacaru, G. C., Fritz, S. R., McIntosh, L. A., Yennello, S. J., & Burns, J. D. (2026). Column-Shipped 211At for Targeted Alpha Therapy: High Radiochemical Conversion in Organotin Astatination via Redox Activation. ACS Organic & Inorganic Au. https://doi.org/10.1021/acsorginorgau.6c00088

Vancouver

Perera JS, Pyles JM, Lawrence CC, Tabacaru GC, Fritz SR, McIntosh LA, et al. Column-Shipped 211At for Targeted Alpha Therapy: High Radiochemical Conversion in Organotin Astatination via Redox Activation. ACS Organic & Inorganic Au. 2026. doi:10.1021/acsorginorgau.6c00088

BibTeX
@article{Perera2026,
  author = {Perera, Jehan S. and Pyles, Jennifer M. and Lawrence, Christine C. and Tabacaru, Gabriel C. and Fritz, Shayden R. and McIntosh, Lauren A. and Yennello, Sherry J. and Burns, Jonathan D.},
  title = {Column-Shipped 211At for Targeted Alpha Therapy: High Radiochemical Conversion in Organotin Astatination via Redox Activation},
  journal = {ACS Organic & Inorganic Au},
  year = {2026},
  doi = {10.1021/acsorginorgau.6c00088}
}
Kostenlos starten →